by Natalie Bourgenies, Attorney @ Harris Bricken Last Friday, January 15th, the U.S. Department of Agriculture (the “USDA”) announced today’s publication of its hemp production final rule in the Federal Register, which will go into effect on March 22, 2021. This final rule builds on the interim final rule (the “IFR”) that was published on […]
Hemp Business Executive
After Two Years Of Work, USDA Publishes National Hemp Rule
THE FINAL RULE, WHICH TAKES EFFECT ON MARCH 22, SETS A HIGHER THC LIMIT — 1% — FOR DETERMINING WHEN PLANTS MUST BE DESTROYED AND MAKES IT EASIER TO DISPOSE OF THEM. Two years after the 2018 farm bill legalized the cultivation of industrial hemp, the USDA completed work on a regulation to oversee production. Some advocates […]
Dozens of CBD Brands In A State of ‘Absolute Panic’ With UK Novel Food Deadline Weeks Away
THE New Year has brought a realisation that the Novel Food deadline is less than three months away leading to ‘absolute panic’ for many CBD brands, say leading industry figures. Gavin Ogilvie is founder and Managing Director of Manchester-based Always Pure Organics, a business which has spent £450,000 submitting three Novel Food applications to the […]
Bold Move To Free CBD From The Shackles Of Novel Food Features A Cannabis Soup Served To A Medieval Pope
EUROPE’S leading hemp trade group is set to make a significant move which could free much of the continent’s CBD industry from the shackles of the Novel Food regime. The European Industrial Hemp Association (EIHA) has spent many months scouring centuries-old historical records to illustrate the widespread use of hemp extracts in foods. It has now amassed […]
Hemp Banking for Credit Unions: Five Key Questions
By Vince Sliwoski, Attorney at Harris Bricken One of the coolest things we’ve done here at Harris Bricken was work with the National Credit Union Association on its June 2020 guidance for servicing hemp-related businesses. Back when we first started working with small, Northwest credit unions in 2014 and 2015 (on the THC banking side) […]
5 Predictions for the Global Cannabinoid Market in 2021
by Dennis O’Neill 2020 has been a transformative year for the cannabis industry. A new presidential administration, several states legalizing cannabis, the passage of the MORE Act in the House, and breakthroughs in biosynthesizing rare cannabinoids were just a few major milestones in a turbulent year. As we begin a new year, what developments can […]
Hemp Litigation: Does Qualified Immunity Protect Law Enforcement Who Wrongly Destroy Hemp?
By Jesse Mondry, Attorney at Harris Bricken Earlier this fall, several news outlets reported on a lawsuit alleging that federal and state law enforcement agencies in California wrongfully destroyed a hemp grow worth more than $3 million. (See here, and here). The case, Agro Dynamics, LLC v. DEA, et al., was filed in the federal […]
European Commission Scraps Moves To Brand CBD A Narcotic – And Cap A Winning Day For Cannabis Industry
THE KanaVape judgement has forced the hand of the The European Commission which has now revised its preliminary determination that CBD (cannabidiol) should be treated as a narcotic. In what has turned out to be a momentous day for the cannabis industry the European Industrial Hemp Association (EIHA) last night said to it was turning its attention to […]
Will This $2m Transatlantic Toxicity Trial Of 15 Animal Species Prove CBD Is Safe?
A TRANS-ATLANTIC collaborative trial which sees 15 different animal species given doses of CBD will conclude next month with the aim of satisfying regulators the popular cannabinoid is safe. The $2m trial on mice, rats, pigs and other species got underway in the United States in September, initiated by UK firm Farmceutica Wellness in collaboration with the […]
CBD’s Differing Effects on Women and Men Under FDA Scrutiny
CBD affects men and women differently, and that could have an impact on how the U.S. regulates the buzzy new substance. Women may be more likely to use it to alleviate pain, sleep difficulties, anxiety and other health issues, according to Amy Abernethy, a top official with the Food and Drug Administration. CBD, the non-psychoactive […]
